
Plans for New Jersey's first four-year private medical school have been announced.

Plans for New Jersey's first four-year private medical school have been announced.

We'll warn you of what's lurking beneath the waves. Mapping the seabed with seismic blasts is making waves in court. And New Jersey's shiny office ...

Millions of empty square feet of office space are in New Jersey, partly because of company movement and advancing technology.

A New Jersey congressman says it’s time to end the shutdown. Plus warnings about the New Jersey courts. And charges against a powerful politician.

The pharmaceutical company's departure from Summit will have economic impacts on local business owners and the municipality.

Governors past and present and the new policy they hope will turn people around. Plus, the Senate president calling for the resignation of Archbishop Myers. ...

Company officials say they would have stayed here, but Hertz’s recent acquisition of another corporation -- Thrifty Dollar -- prompted the need to consolidate and ...

Despite the attention to the big names not in the governor's race, Sen Barbara Buono says her focus has been on her own campaign and ...

Sen. Barbara Buono claims Gov. Chris Christie is in denial about the struggling economy by projecting overinflated tax revenues coming into the state.


James Hughes points out that there is sometimes a disconnect between the unemployment rate and the number of created jobs.

New Jersey Business and Industry Association President Philip Kirschner says his organization favors a tax cut but opposes loopholes to the 2 percent property tax ...



The township of Nutley is bracing for the economic impact of the closure of the Hoffmann-La Roche plant and the loss of close to 1,000 ...

Aaron Birnbaum says Hertz plans to hire about 200 people nationwide to get the company back to its pre-recession levels and expand.

Cutbacks, mergers, and layoffs; intense competition from lower-cost generics; and fierce rivalry from other regions make for a troubled prognosis for NJ’s big drug makers.